Showing 11,801 - 11,820 results of 42,192 for search '(( 50 ((ng decrease) OR (((we decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 1.28s Refine Results
  1. 11801

    DataSheet_1_Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients.pdf by Caleb Nwongbouwoh Muefong (11746673)

    Published 2021
    “…Six months of TB therapy significantly decreased levels of major neutrophil-derived pro-inflammatory mediators: MMP1 (p = 4.90E−12 and p = 2.20E−07), MMP8 (p = 3.40E−14 and p = 1.30E−05) and MMP9 (p = 1.60E−04 and p = 1.50E−03) in plasma and sputum, respectively. …”
  2. 11802

    DataSheet_1_Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients.pdf by Caleb Nwongbouwoh Muefong (11746673)

    Published 2021
    “…Six months of TB therapy significantly decreased levels of major neutrophil-derived pro-inflammatory mediators: MMP1 (p = 4.90E−12 and p = 2.20E−07), MMP8 (p = 3.40E−14 and p = 1.30E−05) and MMP9 (p = 1.60E−04 and p = 1.50E−03) in plasma and sputum, respectively. …”
  3. 11803

    Table_1_Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients.xlsx by Caleb Nwongbouwoh Muefong (11746673)

    Published 2021
    “…Six months of TB therapy significantly decreased levels of major neutrophil-derived pro-inflammatory mediators: MMP1 (p = 4.90E−12 and p = 2.20E−07), MMP8 (p = 3.40E−14 and p = 1.30E−05) and MMP9 (p = 1.60E−04 and p = 1.50E−03) in plasma and sputum, respectively. …”
  4. 11804

    Table_1_Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients.xlsx by Caleb Nwongbouwoh Muefong (11746673)

    Published 2021
    “…Six months of TB therapy significantly decreased levels of major neutrophil-derived pro-inflammatory mediators: MMP1 (p = 4.90E−12 and p = 2.20E−07), MMP8 (p = 3.40E−14 and p = 1.30E−05) and MMP9 (p = 1.60E−04 and p = 1.50E−03) in plasma and sputum, respectively. …”
  5. 11805
  6. 11806

    Effect of fenretinide and its metabolites on SCD expression and activity. by Eugenia Poliakov (116500)

    Published 2017
    “…<p>A) SCD1 protein expression is decreased after treatment with fenretinide, and its metabolite 3-keto-HPR. …”
  7. 11807
  8. 11808
  9. 11809

    Down-regulation of BjsR4 under tellurite and iron stresses, and impact of this down-regulation on survival at high iron concentration. by Julia Hahn (3279486)

    Published 2016
    “…<p><b>A)</b> The steady-state level of BjsR4 is decreased upon addition of tellurite. …”
  10. 11810

    Discovery of <i>N</i>‑(1,3,4-Thiadiazol-2-yl)amide Derivatives as Uncompetitive Inhibitors of 6‑Phosphogluconate Dehydrogenase by Rong Zhang (44942)

    Published 2025
    “…Moreover, <b>19n</b> treatment could result in a decrease of NADPH and Ru-5-P production as well as DNA synthesis in A549 cells. …”
  11. 11811
  12. 11812
  13. 11813
  14. 11814

    An Analysis of Porphyrin Molecular FlexibilityUse of Porphyrin Diacids by Beisong Cheng (2970567)

    Published 1997
    “…Molecular mechanics calculations, using a modified version of MM2(87) and a newly developed force field for porphyrin diacids, correctly predict that the flexibility of <i>meso</i>-tetraaryl porphyrin diacids decreases as the steric bulk of the peripheral substituents increases:  [H<sub>4</sub>TPyP]<sup>2+</sup> ≈ [H<sub>4</sub>TPP]<sup>2+</sup> > [H<sub>4</sub>T-2,6-(OH)<sub>2</sub> PP]<sup>2+</sup> ≈ [H<sub>4</sub>T-2,6-F<sub>2</sub> PP]<sup>2+</sup> > [H<sub>4</sub>T-2,6-Cl<sub>2</sub> PP]<sup>2+</sup> ≈ [H<sub>4</sub>TMP]<sup>2+</sup>. …”
  15. 11815
  16. 11816

    Dataset visualization diagram. by Yaojun Zhang (389482)

    Published 2025
    “…Results on a specialized dataset reveal that YOLOv8n-BWG outperforms YOLOv8n by increasing the mean Average Precision (mAP) by 4.2%, boosting recognition speed by 21.3% per second, and decreasing both the number of floating-point operations (FLOPs) by 28.9% and model size by 26.3%. …”
  17. 11817

    Dataset sample images. by Yaojun Zhang (389482)

    Published 2025
    “…Results on a specialized dataset reveal that YOLOv8n-BWG outperforms YOLOv8n by increasing the mean Average Precision (mAP) by 4.2%, boosting recognition speed by 21.3% per second, and decreasing both the number of floating-point operations (FLOPs) by 28.9% and model size by 26.3%. …”
  18. 11818

    Performance comparison of different models. by Yaojun Zhang (389482)

    Published 2025
    “…Results on a specialized dataset reveal that YOLOv8n-BWG outperforms YOLOv8n by increasing the mean Average Precision (mAP) by 4.2%, boosting recognition speed by 21.3% per second, and decreasing both the number of floating-point operations (FLOPs) by 28.9% and model size by 26.3%. …”
  19. 11819

    C2f and BC2f module structure diagrams. by Yaojun Zhang (389482)

    Published 2025
    “…Results on a specialized dataset reveal that YOLOv8n-BWG outperforms YOLOv8n by increasing the mean Average Precision (mAP) by 4.2%, boosting recognition speed by 21.3% per second, and decreasing both the number of floating-point operations (FLOPs) by 28.9% and model size by 26.3%. …”
  20. 11820

    YOLOv8n detection results diagram. by Yaojun Zhang (389482)

    Published 2025
    “…Results on a specialized dataset reveal that YOLOv8n-BWG outperforms YOLOv8n by increasing the mean Average Precision (mAP) by 4.2%, boosting recognition speed by 21.3% per second, and decreasing both the number of floating-point operations (FLOPs) by 28.9% and model size by 26.3%. …”